Results
eNauka >
Results >
Real-World Outcomes of First-Line Pembrolizumab Monotherapy in Metastatic NSCLC with High PD-L1 Expression (TPS ≥ 50%): A Multicenter Study from Serbia
| Title: | Real-World Outcomes of First-Line Pembrolizumab Monotherapy in Metastatic NSCLC with High PD-L1 Expression (TPS ≥ 50%): A Multicenter Study from Serbia | Authors: | Marković, Filip; Stjepanović, Mihailo   ; Rančić, Milan ; Cekić, Marina; Kontić, Milica |
Issue Date: | 2025 | Publication: | Biomedicines | ISSN: | 2227-9059 Biomedicines Search Idenfier |
Publisher: | Basel, Switzerland : MDPI AG | Type: | Article | Collation: | vol. 13 br. 5 str. 1175 | DOI: | 10.3390/biomedicines13051175 | WoS-ID: | 001497799100001 | Scopus-ID: | 2-s2.0-105006737175 | PMID: | 40427002 | PMCID: | PMC12108898 | URI: | https://enauka.gov.rs/handle/123456789/984076 | URL: | https://www.mdpi.com/2227-9059/13/5/1175 | Project: | Ministry of Education, Science and Technological Development of the Republic of Serbia [200110] |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21M21 |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.